Prognostic value of high-sensitivity C-reactive protein in in-stent restenosis: a meta-analysis of clinical trials

M Yi, L Wu, X Ke - Journal of cardiovascular development and disease, 2022 - mdpi.com
Background: A risk assessment of in-stent restenosis (ISR) patients is critical for providing
adequate treatment. Nevertheless, the prognostic value of high-sensitivity CRP (hs-CRP) …

Prognostic value of type D personality for in-stent restenosis in coronary artery disease patients treated with drug-eluting stent

Y Wang, G Liu, X Gao, Z Zhao, L Li, W Chen… - Psychosomatic …, 2018 - journals.lww.com
Objective To evaluate the predictive value of Type D personality on in-stent restenosis (ISR)
rates at 1 and 2 years post–percutaneous coronary intervention (PCI) in patients with …

The negative affectivity dimension of Type D personality is associated with in-stent neoatherosclerosis in coronary patients with percutaneous coronary intervention …

R Lee, H Yu, X Gao, J Cao, H Tao, B Yu, Y Wang… - Journal of …, 2019 - Elsevier
Objective In-stent neoatherosclerosis (ISNA) is involved in the pathogenesis of in-stent
restenosis and major adverse cardiac events (MACE) in patients with coronary artery …

Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China

M Li, J Hou, X Gu, R Weng, Z Zhong, S Liu - European Journal of Medical …, 2022 - Springer
Background In-stent restenosis (ISR) remains a challenge for coronary artery disease (CAD)
patients who undergo percutaneous coronary intervention (PCI) with stents, and risk factors …

Association between type D personality and in-stent restenosis in patients treated with percutaneous coronary intervention: a mediation analysis of dietary patterns

Y Wang, S Zhang, G Zhang, B Yu, X Gao, Z Dai… - Journal of …, 2020 - Elsevier
Objective Type D personality is a psychosocial risk factor for cardiovascular events and in-
stent restenosis (ISR), but the mechanisms involved are not well understood. This study …

Inflammation and in-stent restenosis

K Demirtas - Angiology, 2018 - journals.sagepub.com
I read the article entitled “Evaluation of the Predictive Value of CHA2DS2-VASc score for In-
Stent Restenosis” by Yilmaz et al1 with great interest. They reported that the CHA2DS2 …

[PDF][PDF] Comparison of clopidogrel vs. ticagrelor medication adherence in patients with acute coronary syndrome.

O Dogan, Z Bulat, A Yildiz, O Abaci… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: Medication nonadherence to dual antiplatelet therapy increases major
cardiovascular events. In this study, we investigated patients' post-acute coronary syndrome …

Predictors of in-stent restenosis

MK Akboga, S Yilmaz - Angiology, 2019 - journals.sagepub.com
Li et al reported in their recent article entitled “Evaluation of Preprocedural Laboratory
Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total …

[HTML][HTML] 冠状动脉支架植入术后再狭窄危险因素的分析

王冬梅, 黄爽, 刘志江, 沈长银, 石蓓, 赵然尊 - 2016 - aammt.tmmu.edu.cn
目的回顾性分析经皮冠状动脉支架植入术后复查冠状动脉造影患者冠状动脉支架内再狭窄(in-
stent restenosis, ISR) 的相关危险因素. 方法纳入2007 年1 月至2015 年5 月在遵义医学院附属 …

Protective drugs against Risk of Intra-coronary Stent‎ Restenosis‎

TA Abdelaziz, RH Mohammad, MM Gad… - Journal of Advanced …, 2020 - japer.in
Background: Intracoronary stent restenosis (ISR) is a famous catastrophe, always following
percutaneous coronary interventions (PCI). Many investigations were performed to avoid …